Longitudinal clinicopathological follow up of breast cancer patients from 1988 to 1996 in Jakarta

Didid Tjindarbumi, Gunawan Tjahjadi, Muchlis Ramli, Yoshiyuki Ohno, Idral Darwis, Goi Sakamoto, Santoso Cornain, Esti Soetrisno, Joedo Prihartono, Endang Sri Roostini Hardianto, Setyawati Budiningsih, Kenji Wakai, Drupadi Harnopidjati

Research output: Contribution to journalArticlepeer-review


Breast cancer belongs to the leading cancer among Indonesian women, it ranked second to the cancer of the uterine cervix. A collaborative study on the etiology and clinicopathology of breast cancer between Japan and Indonesia has been carried out. This study was started in 1988 and conducted in 2 batches. The first was between 1988-1992, where 300 cases and 600 controls were studied, which was extended with, the second batch from 1992-1996, for further nutritional analysis on 226 and 452 controls. This paper will discuss the 5 year longitudinal clinicopathological follow up observation on 110 operable cases belonging to the 300 1st batch patients. The remaining 190 patients were late cases and were not suitable for this project since many of them were in a worse condition. The operable patients (75) from the 2nd batch (226) were not included since the 5 year survival analysis would not be done until, the year 2001. Among 10 operable breast cancer admitted between 1989 through 1992, we found 43 (39%) patients died in the hospital or at their own home, 33 (30%) patients are alive without recurrence and 34 (31%) patients are alive, but with recurrence or metastatic disease. The overall 5 year survival rate was 68.8% with the following details: 87.5% from Stage I, 61.3% from Stage II and 57.8% from Stage IIIA.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalMedical Journal of Indonesia
Issue number2
Publication statusPublished - 1 Apr 1999


  • Breast cancer
  • Clinicopathological
  • Longitudinal study
  • Operable cases
  • Survival analysis


Dive into the research topics of 'Longitudinal clinicopathological follow up of breast cancer patients from 1988 to 1996 in Jakarta'. Together they form a unique fingerprint.

Cite this